Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report

ConclusionThe current study suggests that nivolumab may be a viable option for patients with metastatic primary malignant melanoma of the esophagus. Additional evidence from future clinical trials and research is necessary to fully validate these findings.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research